Supply of CAR-T preparations (axicabtagene ciloleucel, lisocabtagene maraleucel)
Originaltitel der Bekanntmachung
Poland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – DZP.242.281.2026 -Dostawa produktów leczniczych – preparaty CAR-T [Axicabtagene ciloleucel, Lisocabtagene maraleucel]
Opportunity Score
Warum diese Bewertung?
Chance
50 / 100
Komplexität
25 / 100
Risikofaktoren
No estimated value disclosed; may indicate low budget or hidden constraints.
Structured data indicates EU funding, XML indicates no EU funds. Could affect contract terms or audit requirements.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Eckdaten der Ausschreibung
- Öffentlicher Auftraggeber
- UNIWERSYTECKI SZPITAL KLINICZNY IM. JANA MIKULICZA-RADECKIEGO WE WROCŁAWIU
- Land
- Polen
- CPV
- 33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
- Frist
- Jul 27, 2026
Überblick
Moderate opportunityWichtige Fakten
- Supplies contract
- 2 lots
- Duration 12 MONTH
- Supply of CAR-T medicinal products: Axicabtagene ciloleucel (Lot 1) and Lisocabtagene maraleucel (Lot 2).
- Delivery to Wrocław, Poland.
Vollständige Zusammenfassung anzeigen
Open tender by Uniwersytecki Szpital Kliniczny we Wrocławiu for supply of CAR-T medicinal products: Axicabtagene ciloleucel (Lot 1) and Lisocabtagene maraleucel (Lot 2). Two lots, each for one task. Award based solely on lowest price. Duration 12 months. No financial or technical eligibility conditions required beyond standard business registration and, for pharmaceutical wholesalers, a permit from the Chief Pharmaceutical Inspector. Estimated value not disclosed. EU funding flag inconsistent between structured data (true) and XML (no EU funds). Language of procedure: Polish. Deadline for submission: 2026-07-27 10:00 Warsaw time.
Risiken
No estimated value disclosed; may indicate low budget or hidden constraints.
Structured data indicates EU funding, XML indicates no EU funds. Could affect contract terms or audit requirements.
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Tenderers must be registered in KRS (Poland) or equivalent business register.
- Pharmaceutical wholesalers must hold a permit from the Chief Pharmaceutical Inspector under the Pharmaceutical Law.
Administrative
- Electronic submission via the procurement platform (platformazakupowa.pl).
Zuschlagskriterien
Lot 1
Lot 2
Auftraggeber
Ort
WROCŁAW, POL
Website
Auftraggeberprofil
Kennung
8981816856
Tätigkeit
Health
Lose (2)
LOT-0001
Position 1 - Axicabtagene ciloleucel
Supply of Axicabtagene ciloleucel (CAR-T therapy). One task. Duration 12 months. Place of performance: Wrocław, Poland.
PLN 0
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Za ofertę najkorzystniejszą zostanie uznana oferta zawierająca najniższą cenę: „Cena” – C
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
POZYCJA NR 1
Originale TED-Beschreibung
POZYCJA NR 1 - Axicabtagene ciloleucel - 1 ZADANIE
LOT-0002
Position 2 - Lisocabtagene maraleucel
Supply of Lisocabtagene maraleucel (CAR-T therapy). One task. Duration 12 months. Place of performance: Wrocław, Poland.
PLN 0
Geschätzter Wert
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Za ofertę najkorzystniejszą zostanie uznana oferta zawierająca najniższą cenę: „Cena” – C
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
POZYCJA NR 2
Originale TED-Beschreibung
POZYCJA NR 2 - Lisocabtagene maraleucel - 1 ZADANIE
Vergabedetails
- Veröffentlichungsdatum
- 24 Jun 2026
- Sprachen
- Polish
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 435226-2026
Dokumente (1)
Ähnliche Ausschreibungen
Czechia – Specialised chemical products – DNS - chemikálie pro molekulární a buněčnou biologii
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Lithuania – Pharmaceutical products – Vaistų ir kitų farmacijos produktų pirkimas
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на ВМА и подчинените й структури
Lithuania-Kaunas: General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Opportunity Score
Warum diese Bewertung?
Chance
50 / 100
Komplexität
25 / 100
Risikofaktoren
No estimated value disclosed; may indicate low budget or hidden constraints.
Structured data indicates EU funding, XML indicates no EU funds. Could affect contract terms or audit requirements.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications